Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China
· Delayed Price · Currency is CNY 7.02
+0.06 (0.86%)
Apr 30, 2025, 3:04 PM CST
SHE:002566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 42.93 | 52.09 | 94.73 | 83.1 | 96.02 | 80.06 | Upgrade
|
| Depreciation & Amortization | 46.93 | 46.93 | 48.93 | 44.27 | 43.09 | 40.67 | Upgrade
|
| Other Amortization | 0.77 | 0.77 | 1.53 | 0.92 | 1.18 | 0.43 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.29 | -0.29 | -0.78 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.27 | 0.27 | 0.24 | 0.27 | 0.28 | -0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.7 | -11.7 | -4.02 | -2.62 | -0.25 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 1.27 | -0.46 | 6.15 | Upgrade
|
| Other Operating Activities | 2.17 | 13.75 | 10.88 | 19.99 | 22.41 | 25.39 | Upgrade
|
| Change in Accounts Receivable | 5.21 | 5.21 | 75.22 | -17.02 | -31.92 | -40.18 | Upgrade
|
| Change in Inventory | -11.33 | -11.33 | -12.65 | -4.99 | 17.85 | 15.54 | Upgrade
|
| Change in Accounts Payable | -37.26 | -37.26 | -7.09 | 18.54 | 64.21 | 77.19 | Upgrade
|
| Operating Cash Flow | 38.21 | 58.94 | 209.13 | 145.86 | 215.1 | 203.51 | Upgrade
|
| Operating Cash Flow Growth | -77.73% | -71.81% | 43.38% | -32.19% | 5.69% | -3.49% | Upgrade
|
| Capital Expenditures | -10.52 | -15.94 | -35.77 | -41.36 | -107.07 | -75.93 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.23 | 0.45 | 0.74 | - | 0 | 0.1 | Upgrade
|
| Investment in Securities | -425.02 | -365 | -40 | 40 | -100 | - | Upgrade
|
| Other Investing Activities | 3.31 | 5.29 | 1.64 | 3.13 | - | - | Upgrade
|
| Investing Cash Flow | -432.01 | -375.21 | -73.39 | 1.77 | -207.06 | -75.84 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 430 | 397.45 | - | Upgrade
|
| Long-Term Debt Issued | - | 600 | 520 | - | - | 485 | Upgrade
|
| Total Debt Issued | 675 | 600 | 520 | 430 | 397.45 | 485 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -400 | -415 | - | Upgrade
|
| Long-Term Debt Repaid | - | -638.35 | -484.84 | -3.06 | -5.75 | -360.47 | Upgrade
|
| Total Debt Repaid | -673.35 | -638.35 | -484.84 | -403.06 | -420.75 | -360.47 | Upgrade
|
| Net Debt Issued (Repaid) | 1.65 | -38.35 | 35.16 | 26.94 | -23.3 | 124.53 | Upgrade
|
| Common Dividends Paid | -62.31 | -61.64 | -29.86 | - | -23.32 | -29.54 | Upgrade
|
| Other Financing Activities | -0.84 | - | 3.43 | -50.99 | -28.72 | 1.32 | Upgrade
|
| Financing Cash Flow | -61.51 | -99.99 | 8.73 | -24.06 | -75.34 | 96.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -455.31 | -416.25 | 144.47 | 123.57 | -67.3 | 223.98 | Upgrade
|
| Free Cash Flow | 27.69 | 43 | 173.36 | 104.49 | 108.04 | 127.58 | Upgrade
|
| Free Cash Flow Growth | -80.97% | -75.19% | 65.91% | -3.28% | -15.32% | -32.56% | Upgrade
|
| Free Cash Flow Margin | 4.41% | 6.43% | 20.31% | 12.59% | 12.31% | 15.14% | Upgrade
|
| Free Cash Flow Per Share | 0.08 | 0.13 | 0.52 | 0.32 | 0.33 | 0.39 | Upgrade
|
| Cash Income Tax Paid | 94.04 | 96.65 | 113.44 | 100.26 | 98.63 | 116.02 | Upgrade
|
| Levered Free Cash Flow | -7.94 | -3.04 | 94.72 | 77.27 | 5.5 | 45.22 | Upgrade
|
| Unlevered Free Cash Flow | 0.71 | 5.61 | 103.26 | 86.04 | 13.85 | 53.4 | Upgrade
|
| Change in Net Working Capital | 54.25 | 48.62 | -21.79 | -26.76 | -5.42 | -27.37 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.